Try our Advanced Search for more refined results
LTS Lohmann Therapie-Systeme AG
-
Order | Filed: April 25, 2024 | Entered: April 25, 2024 UCB, Inc. et al v. Mylan Technologies Inc.
Patent - Abbreviated New Drug Application(ANDA) | Vermont
Stipulation and Order ~Util - Set Scheduling Order Deadlines
STIPULATION AND ORDER to Extend Deadlines: Discovery due by 6/6/2024; Motions due by 6/6/2024; Ready for Trial by 6/13/2024. Signed by Judge Christina Reiss on 4/25/2024. (law)
-
Misc | Filed: April 24, 2024 | Entered: April 24, 2024 UCB, Inc. et al v. Mylan Technologies Inc.
Patent - Abbreviated New Drug Application(ANDA) | Vermont
Proposed Order
PROPOSED Order by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. (Berger, Ritchie)
-
Misc | Filed: April 23, 2024 | Entered: April 23, 2024 UCB, Inc. et al v. Actavis Laboratories UT, Inc.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Acknowledgment of Receipt
ACKNOWLEDGMENT OF RECEIPT of Defendant's trial exhibits. Acknowledgment filed by Melanie K. Sharp on behalf of Defendant Actavis Laboratories UT, Inc. (mpb)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login